Syndax Pharmaceuticals Inc. (SNDX) intrinsic value & 10-year financials
Syndax Pharmaceuticals Inc. (SNDX) has a Graham intrinsic value of $15.28 per share. At $12.90 on Oct 17, 2026, the stock trades 16% below that value. Over the last 10 fiscal years revenue grew 73.3% a year to $172.4M, with an average return on invested capital of -155.0%.
- Graham intrinsic value
- $15.28
- Share price (Oct 17, 2026)
- $12.90
- Price vs Graham value
- 16% below
- Market cap
- $1.1B
- Revenue (FY2025)
- $172.4M
- Revenue growth (10-yr CAGR)
- 73.3%
- ROIC (10-yr avg)
- -155.0%
- Free cash flow (FY2025)
- -$323.2M
SNDX 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $172.4M | -$285.4M | -$3.29 | -$323.2M | -158.4% | -50.3% |
| FY2024 | $23.7M | -$318.8M | -$3.72 | — | -1434.4% | -59.9% |
| FY2023 | $0 | -$209.4M | -$2.98 | — | — | -64.1% |
| FY2022 | $0 | -$149.3M | -$2.46 | — | — | -51.4% |
| FY2021 | $139.7M | $24.9M | $0.46 | $29.0M | 18.8% | 16.2% |
| FY2020 | $1.5M | -$73.2M | -$1.87 | — | -4708.2% | -98.9% |
| FY2019 | $1.5M | -$56.0M | -$1.84 | — | -3792.9% | -776.5% |
| FY2018 | $1.5M | -$74.0M | — | -$68.7M | -5001.7% | — |
| FY2017 | $2.1M | -$60.8M | — | -$47.5M | -2939.0% | — |
| FY2016 | $1.2M | -$44.5M | — | -$35.4M | -3587.4% | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Syndax Pharmaceuticals Inc is a consistent compounder, expanding top-line revenue at 73.3% annually over the past decade.
Syndax Pharmaceuticals Inc has historically struggled to out-earn its cost of capital, averaging just -45.2% ROIC.
Syndax Pharmaceuticals Inc capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Syndax Pharmaceuticals Inc is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $15.28 per share.